New Treatment Breakthrough for Ankylosing Spondylitis: Infliximab Shows Promising Results

The video discusses ankylosing spondylitis (AS), a condition affecting the spine and joints, causing pain and curvature of the back. Infliximab, a drug previously used for rheumatoid arthritis and Crohn's disease, has been licensed in Europe for AS treatment. It is the first anti-tumor necrosis factor alpha drug used for AS, showing promising results in reducing pain and stiffness, unlike traditional painkillers. Ongoing trials continue to demonstrate its effectiveness.

What new insight or understanding did you gain from this video?